Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cellectis (CLLS)

  • Event
  • June 30, 2022, 10:31 UTC
  • 18
  • 1 comments

(99% Neutral) Cellectis (CLLS) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • June 30, 2022, 10:27 UTC
  • 19
  • 1 comments

(90% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K)

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • June 30, 2022, 10:08 UTC
  • 19
  • 1 comments

(99% Neutral) HUTCHMED DRC (HCM) Files Form 6-K

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • June 29, 2022, 10:27 UTC
  • 19
  • 1 comments

(99% Neutral) HUTCHMED DRC (HCM) Files Form 6-K

Comment Full text

Cellectis (CLLS)

  • Event
  • June 28, 2022, 20:45 UTC
  • 19
  • 1 comments

(99% Neutral) Cellectis (CLLS) Announces Clinical Development Update (Form 6-K)

Comment Full text

Cellectis (CLLS)

  • Event
  • June 28, 2022, 20:17 UTC
  • 19
  • 1 comments

(99% Neutral) Cellectis (CLLS) Announces 2022 Annual General Meeting

Comment Full text

ObsEva SA (company was delisted NASDAQ) (OBSV)

  • Event
  • June 28, 2022, 20:13 UTC
  • 19
  • 1 comments

(70% Positive) ObsEva SA (company was delisted NASDAQ) (OBSV) Announces Regulatory Update (Form 6-K)

Comment Full text

Achilles Therapeutics plc (ACHL)

  • Event
  • June 28, 2022, 20:03 UTC
  • 19
  • 1 comments

(99% Neutral) Achilles Therapeutics plc (ACHL) Announces 2021 Annual General Meeting

Comment Full text

Sanofi (SNY)

  • Event
  • June 28, 2022, 19:59 UTC
  • 19
  • 1 comments

(90% Positive) Sanofi (SNY) Announces Regulatory Update (Form 6-K)

Comment Full text

CureVac (CVAC)

  • Event
  • June 27, 2022, 20:16 UTC
  • 19
  • 1 comments

(99% Neutral) CureVac (CVAC) Files Form 6-K

Comment Full text
  • Previous
  • 568
  • 569
  • 570
  • 571
  • 572
  • Next

Search

News categories

  • Technical Exchange News(12514)
  • Event(6229)
  • SEC News(284549)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162171)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin